The OncoExTraTM test is an ultra-comprehensive genomic profiling assay that incorporates tumor whole exome (DNA) and whole transcriptome (RNA) sequencing with paired tumor-normal analysis to identify alterations/biomarkers in individuals diagnosed with advanced cancers. These insights can help inform targeted therapy options and clinical trials eligibility.
With ~20,000 genes profiled, an assessment of key immuno-oncology signatures (TMB & MSI), clinical trial availability, and Medicare coverage, the OncoExTra test is designed to provide actionable insights to help inform clinical decision making for a breadth of solid tumor types.